Detalles de la búsqueda
1.
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials.
Circulation
; 149(11): 825-838, 2024 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38059368
2.
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF.
Circulation
; 147(22): 1670-1683, 2023 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37039015
3.
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
Circulation
; 148(22): 1735-1745, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37632455
4.
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.
J Card Fail
; 30(1): 26-35, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37683911
5.
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
Eur Heart J
; 44(24): 2170-2183, 2023 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220172
6.
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.
Eur Heart J
; 44(31): 2966-2977, 2023 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210742
7.
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.
Circulation
; 145(3): 158-169, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34743554
8.
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF.
Circulation
; 146(13): 980-994, 2022 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35971840
9.
Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF.
Circulation
; 146(6): 438-449, 2022 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35442064
10.
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials.
Lancet
; 400(10354): 757-767, 2022 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36041474
11.
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.
Diabetes Obes Metab
; 25(11): 3327-3336, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37580309
12.
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.
Ann Intern Med
; 175(6): 820-830, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35467935
13.
Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
Circulation
; 144(3): 199-209, 2021 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33983794
14.
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF.
Circulation
; 143(20): 1962-1972, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33832352
15.
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
Circulation
; 143(6): 516-525, 2021 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33186500
16.
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF.
Circulation
; 143(4): 298-309, 2021 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33040613
17.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med
; 381(21): 1995-2008, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31535829
18.
Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis.
Rheumatology (Oxford)
; 61(11): 4374-4383, 2022 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35136973
19.
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?
Eur Heart J Suppl
; 24(Suppl L): L10-L19, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36545228
20.
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
Eur Heart J
; 42(36): 3727-3738, 2021 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34448003